SpringWorks Therapeutics, Inc.

SWTX

N/A

NASDAQBiotechnology🇺🇸North America

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Jul 15, 2026

29w

Drug Pipeline

Drug Name	Phase	Indication	Designations
Placebo Oral Tablet	Phase 3	Desmoid Tumor	-
Mirdametinib (PD-0325901) oral capsule or dispersible tablet	Phase 2	Plexiform Neurofibroma	-
Nirogacestat oral tablet	Phase 2	Desmoid Tumor	-
Nirogacestat	Phase 2	Ovarian Granulosa-Stromal Tumor	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

July 2026~Nirogacestat

Primary completion for Nirogacestat trial (NCT05348356) in Ovarian Granulosa-Stromal Tumor

Regulatory Approvals

SWTX News